Related references
Note: Only part of the references are listed.Diagnosis and staging of hepatocellular carcinoma (HCC): current guidelines
Carmen Ayuso et al.
EUROPEAN JOURNAL OF RADIOLOGY (2018)
Targets for immunotherapy of liver cancer
Tim F. Greten et al.
JOURNAL OF HEPATOLOGY (2018)
The immunology of hepatocellular carcinoma
Marc Ringelhan et al.
NATURE IMMUNOLOGY (2018)
Hepatitis C Virus and Hepatocellular Carcinoma: A Narrative Review
Page Axley et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2018)
Aspirin Suppresses Growth in PI3K-Mutant Breast Cancer by Activating AMPK and Inhibiting mTORC1 Signaling
Whitney S. Henry et al.
CANCER RESEARCH (2017)
Incidence and predictors of portal and splenic vein thrombosis after pure laparoscopic splenectomy
Nicola de'Angelis et al.
SURGERY (2017)
Hypersplenism is correlated with increased risk of hepatocellular carcinoma in patients with post-hepatitis cirrhosis
Xing Lv et al.
TUMOR BIOLOGY (2016)
Aspirin and colorectal cancer: the promise of precision chemoprevention
David A. Drew et al.
NATURE REVIEWS CANCER (2016)
A comparative study of two anti-coagulation plans on the prevention of PVST after laparoscopic splenectomy and esophagogastric devascularization
Zhe Cheng et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2015)
Portal Vein Thrombosis
Yogesh K. Chawla et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2015)
Molecular targets of aspirin and cancer prevention
L. Alfonso et al.
BRITISH JOURNAL OF CANCER (2014)
Management of portal vein thrombosis in liver cirrhosis
Xingshun Qi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2014)
Benefits and risks of splenectomy
Elroy P. Weledji
INTERNATIONAL JOURNAL OF SURGERY (2014)
Role of splenectomy in patients with hepatocellular carcinoma and hypersplenism
Sung Hoon Kim et al.
ANZ JOURNAL OF SURGERY (2013)
Synergistically killing activity of aspirin and histone deacetylase inhibitor valproic acid (VPA) on hepatocellular cancer cells
Xiaofei Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
Hashem B. El-Serag
GASTROENTEROLOGY (2012)
Nonsteroidal Anti-inflammatory Drug Use, Chronic Liver Disease, and Hepatocellular Carcinoma
Vikrant V. Sahasrabuddhe et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Anticoagulation therapy prevents portal-splenic vein thrombosis after splenectomy with gastroesophageal devascularization
Wei Lai et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Association between NSAIDs use and breast cancer risk: a systematic review and meta-analysis
Ya-shuang Zhao et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
The postoperative splenic/portal vein thrombosis after splenectomy and its prevention - an unresolved issue
Maria-Theresa Krauth et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2008)
Modifications produced by selective inhibitors of cyclooxygenase and ultra low dose aspirin on platelet activity in portal hypertension
Francisco X. Eizayaga et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Portal vein thrombosis; risk factors, clinical presentation and treatment
Kirstine K. Sogaard et al.
BMC GASTROENTEROLOGY (2007)
High incidence of thrombosis of the portal venous system after laparoscopic splenectomy
M Ikeda et al.
ANNALS OF SURGERY (2005)
Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis
L Amitrano et al.
JOURNAL OF HEPATOLOGY (2004)
Portal vein thrombosis after splenectomy
ER Winslow et al.
AMERICAN JOURNAL OF SURGERY (2002)
Splenectomy in patients with hepatocellular carcinoma and hypersplenism
Y Sugawara et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2000)